Back to Community

Semaglutide Dose Escalation

Trending
SemaglutideWeight Loss521 users

Structured GLP-1 agonist protocol following clinical dose-escalation guidelines. The most-tracked protocol on the platform with the highest average outcome scores for weight management.

Total Users

521

Avg. Improvement

82%

Median Time to Effect

Day 7 median

Completion Rate

75%

389 of 521

Outcome Distribution

Self-reported improvement scores across all completed experiments

Dosing Breakdown

Start 0.25mg subcutaneous weekly for 4 weeks. Increase to 0.5mg for 4 weeks, then 1.0mg for 4 weeks. Optionally increase to 1.7mg and 2.4mg in subsequent 4-week blocks based on tolerability.

Duration

16 weeks average

Target Outcomes

  • Significant weight loss (10-15% body weight)
  • Reduced appetite and cravings
  • Improved glycemic control
  • Reduced visceral fat
Common Side Effects

Reported frequency among 389 completed experiments

Nausea37%
Reduced appetite28%
Diarrhea16%
Constipation14%
Fatigue11%
Injection site reaction8%

Start this protocol

Create a new experiment based on this community protocol

Start Experiment

Medical disclaimer: This data is aggregated from anonymous self-reported experiments and does not constitute medical advice. Results vary significantly between individuals. These compounds are not FDA-approved for the listed uses (unless otherwise noted). Always consult a qualified healthcare provider before beginning any peptide protocol.